Beijing Tong Ren Tang Chinese Medicine Company Limited (FRA:TQR)

FRA:TQR Balance Sheet

Financials in millions HKD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,789	1,773	999.81	1,991	1,660	1,426
Short-Term Investments	233.92	59.89	1,398	271.33	633.02	440.37
Cash & Short-Term Investments	2,023	1,833	2,398	2,262	2,293	1,866
Cash Growth	12.81%	-23.57%	6.00%	-1.35%	22.87%	-6.09%
Accounts Receivable	408.85	501.08	395.24	923.23	526.48	546.45
Other Receivables	13.83	24.93	27.74	18.77	16.06	0.97
Receivables	422.68	526.01	422.99	942	542.54	547.42
Inventory	1,457	1,589	1,012	469.78	431.87	495.38
Prepaid Expenses	21.42	17.76	11.62	8.99	9.09	23.74
Total Current Assets	3,925	3,966	3,844	3,683	3,277	2,933
Property, Plant & Equipment	432.59	412.35	425.63	393.35	397.56	381.82
Long-Term Investments	62.33	62.19	59.8	62.61	63.36	23.87
Goodwill	49.42	49.42	49.42	49.42	49.42	49.42
Other Intangible Assets	16.53	17.89	6.97	10.29	11.53	5.42
Long-Term Deferred Tax Assets	31.8	35.49	37.12	14.81	22.05	13.06
Other Long-Term Assets	16.89	16.45	11.19	11.72	14.25	10.43
Total Assets	4,534	4,560	4,434	4,225	3,835	3,417
Accounts Payable	50.41	38.34	176.98	153.71	34.6	74.13
Accrued Expenses	68.45	113.83	65.22	77.03	88.45	62.27
Current Portion of Long-Term Debt	0.07	0.07	0.17	0.22	0.48	0.26
Current Portion of Leases	58.21	57.41	56.25	42.13	52.72	40.6
Current Income Taxes Payable	31.39	20.57	28.09	140.81	32.31	35.62
Current Unearned Revenue	7.44	5.14	3.21	4.68	4.51	3.73
Total Current Liabilities	215.98	235.35	329.92	418.57	213.06	216.62
Long-Term Debt	0.11	0.14	0.17	0.33	0.8	2.05
Long-Term Leases	84.32	65.8	75.23	60.4	74.48	63.1
Long-Term Deferred Tax Liabilities	8.76	8.71	8.44	7.18	7.15	5.7
Other Long-Term Liabilities	3.09	3.09	-	-	-	-
Total Liabilities	312.26	313.09	413.76	486.49	295.48	287.46
Common Stock	938.79	938.79	938.79	938.79	938.79	938.79
Retained Earnings	3,143	3,201	2,977	2,713	2,511	2,104
Comprehensive Income & Other	-53.35	-64.61	-49.42	-47.3	-31.4	-25.15
Total Common Equity	4,029	4,075	3,867	3,604	3,418	3,017
Minority Interest	193.71	171.07	154.18	134.31	121.33	112.02
Shareholders' Equity	4,222	4,246	4,021	3,739	3,540	3,130
Total Liabilities & Equity	4,534	4,560	4,434	4,225	3,835	3,417
Total Debt	142.71	123.42	131.81	103.08	128.48	106.01
Net Cash (Debt)	1,880	1,710	2,266	2,159	2,165	1,760
Net Cash Growth	13.32%	-24.57%	4.96%	-0.26%	22.98%	-6.73%
Net Cash Per Share	2.25	2.04	2.71	2.58	2.59	2.10
Filing Date Shares Outstanding	837.1	837.1	837.1	837.1	837.1	837.1
Total Common Shares Outstanding	837.1	837.1	837.1	837.1	837.1	837.1
Working Capital	3,709	3,730	3,514	3,264	3,064	2,716
Book Value Per Share	4.81	4.87	4.62	4.31	4.08	3.60
Tangible Book Value	3,963	4,008	3,810	3,545	3,357	2,963
Tangible Book Value Per Share	4.73	4.79	4.55	4.23	4.01	3.54
Land	-	59.29	61.48	61.36	48.82	48.82
Buildings	-	145.29	147.45	146.71	134.46	134.21
Machinery	-	128.03	119.28	108.43	109.86	105.92
Leasehold Improvements	-	81.11	80.55	72.25	68.21	67.75

Source: S&P Global Market Intelligence. Standard template. Financial Sources.